<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Aging Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Aging Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Aging Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Aging Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="epub">1663-4365</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31680937</article-id>
<article-id pub-id-type="pmc">6813195</article-id>
<article-id pub-id-type="doi">10.3389/fnagi.2019.00284</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Mini Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Neuroinflammation and the Gut Microbiota: Possible Alternative Therapeutic Targets to Counteract Alzheimer’s Disease?</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Cerovic</surname>
<given-names>Milica</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/824773/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Forloni</surname>
<given-names>Gianluigi</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/175718/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Balducci</surname>
<given-names>Claudia</given-names>
</name>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/158253/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><institution>Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri, IRCCS</institution>, <addr-line>Milan</addr-line>, <country>Italy</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Patrizia Giannoni, University of Nîmes, France</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Jasenka Zubcevic, University of Florida, United States; Stephen D. Ginsberg, Nathan Kline Institute for Psychiatric Research, United States</p>
</fn>
<corresp id="c001">*Correspondence: Claudia Balducci <email>claudia.balducci@marionegri.it</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>18</day>
<month>10</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>11</volume>
<elocation-id>284</elocation-id>
<history>
<date date-type="received">
<day>28</day>
<month>6</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>03</day>
<month>10</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2019 Cerovic, Forloni and Balducci.</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>Cerovic, Forloni and Balducci</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Alzheimer’s disease (AD) is a complex, multi-factorial disease affecting various brain systems. This complexity implies that successful therapies must be directed against several core neuropathological targets rather than single ones. The scientific community has made great efforts to identify the right AD targets beside the historic amyloid-β (Aβ). Neuroinflammation is re-emerging as determinant in the neuropathological process of AD. A new theory, still in its infancy, highlights the role of gut microbiota (GM) in the control of brain development, but also in the onset and progression of neurodegenerative diseases. Bidirectional communication between the central and the enteric nervous systems, called gut-brain axes, is largely influenced by GM and the immune system is a potential key mediator of this interaction. Growing evidence points to the role of GM in the maturation and activation of host microglia and peripheral immune cells. Several recent studies have found abnormalities in GM (dysbiosis) in AD populations. These observations raise the intriguing question whether and how GM dysbiosis could contribute to AD development through action on the immune system and whether, in a therapeutic prospective, the development of strategies preserving a healthy GM might become a valuable approach to prevent AD. Here, we review the evidence from animal models and humans of the role of GM in neuroinflammation and AD.</p>
</abstract>
<kwd-group>
<kwd>Alzhimer’s disease</kwd>
<kwd>neuroinflammation</kwd>
<kwd>gut microbiota</kwd>
<kwd>immune cells</kwd>
<kwd>therapy</kwd>
</kwd-group>
<counts>
<fig-count count="2"></fig-count>
<table-count count="0"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="104"></ref-count>
<page-count count="9"></page-count>
<word-count count="6956"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="introduction">
<title>Introduction</title>
<p>Alzheimer’s disease (AD) remains the most spread form of dementia afflicting 45 million people worldwide and continuously challenging the scientific community in the hard task of identifying a therapy. AD pathogenesis starts around 15–20 years before the clinical symptoms become detectable. Within this time frame, the patient’s brain accumulates multiple-system damages including synaptic and mitochondrial alterations, vessel damage, chronic neuroinflammation, cognitive dysfunctions and neuronal cell death. amyloid-β (Aβ) extracellular plaques and intracellular neurofibrillary tangles enriched of hyperphosphorylated Tau protein are the two main histological brain lesions. Aβ is still held to be the main culprit, especially in its soluble oligomeric form. Aβ oligomers are indeed considered as the most neurotoxic species and the best correlates of disease severity (Forloni et al., <xref ref-type="bibr" rid="B23">2016</xref>). However, Aβ can no longer be considered the sole target because of the multiple failures in anti-Aβ trials (Panza et al., <xref ref-type="bibr" rid="B63">2019</xref>). More likely, the complex pathological condition of AD conceivably calls for alternative targets and multi-target therapies.</p>
<p>Based on these considerations, this review aims to highlight two therapeutic targets, which are attracting much attention in the fight against AD: neuroinflammation and the gut microbiota (GM). The former has strongly re-emerged as crucial in the neuropathogenic process of AD, whereas the latter, though still in its infancy, is attracting interest as a promising new alternative target. Both systems intimately interact in physiology and pathology.</p>
</sec>
<sec id="s2">
<title>Neuroinflammation and AD</title>
<p>A large body of evidence has accumulated in the last few years on the vital role of neuroinflammation in the pathogenetic process of AD. In physiological conditions glial cells are determinants in the regulation of brain development, neuronal activity and survival. Microglia patrol the brain microenvironment guaranteeing its defense from exogenous pathogens or endogenous dangers. In response to bacterial and viral infections or brain damage, microglia are rapidly activated and phagocytize pathogens, including Aβ, and damaged neurons. With elimination of harmful stimulus, neuroinflammation is resolved and microglia return to a resting state. In AD, neuroinflammation is chronic and resolution is not achieved. This implies that microglia constantly release pro-inflammatory cytokines, favoring neuronal cell death (Heneka et al., <xref ref-type="bibr" rid="B35">2015</xref>). Indeed, many of the inflammatory mediators, such as pro-inflammatory cytokines, chemokines as well as factors of the complement system are produced locally and elevated in the brain of AD patients (Rogers et al., <xref ref-type="bibr" rid="B67">1992</xref>; McGeer and McGeer, <xref ref-type="bibr" rid="B58">2002</xref>). The most representative cytokines of AD are IL1β, TNFα and IL6, all up-regulated in AD tissues and prominently associated with AD lesions (Griffin et al., <xref ref-type="bibr" rid="B32">1989</xref>; Dickson et al., <xref ref-type="bibr" rid="B15">1993</xref>). It was recently demonstrated that neurodegeneration very likely involves astrocytes which, by taking on a microglia-induced A1 pro-inflammatory phenotype, would promote neuronal cell death, with TNFα as the most prominent mediator (Fiala and Veerhuis, <xref ref-type="bibr" rid="B20">2010</xref>; Liddelow et al., <xref ref-type="bibr" rid="B50">2017</xref>). In addition, activated microglia loses their phagocytic properties, thus reducing the degree of Aβ phagocytosis, and consequently promoting its accumulation (Krabbe et al., <xref ref-type="bibr" rid="B46">2013</xref>). These findings are supported by the discovery of a relation between an increase in AD risk and mutations in genes encoding immune receptors such as TREM2, myeloid cell surface antigen CD33 and CR1 (Balducci and Forloni, <xref ref-type="bibr" rid="B2">2018</xref>). This was compelling since they are all expressed on myeloid cells, thus demonstrating that alterations in microglial biology are linked to AD pathogenesis and an increased risk of its development. Of note, a series of transcriptomic and proteomic analysis of inflammatory cells might provide biomarkers for preclinical detection as well as insights on progression from MCI to AD condition (Fiala and Veerhuis, <xref ref-type="bibr" rid="B20">2010</xref>; Wes et al., <xref ref-type="bibr" rid="B93">2016</xref>; Rangaraju et al., <xref ref-type="bibr" rid="B66">2018</xref>; Bonham et al., <xref ref-type="bibr" rid="B6">2019</xref>).</p>
<p>A close relation has also been described between primed microglia and cognitive dysfunction. In healthy tissue, microglia have a ramified morphology and the prolongations constantly survey synaptic activity. Phagocytic microglia have an important role in synaptic pruning and refinement in the developing nervous system (Weinhard et al., <xref ref-type="bibr" rid="B91">2018</xref>). The most intriguing mechanism explaining memory dysfunction in AD implies that Aβ oligomers, the most toxic species, foster microglial activation which then excessively engulf and eliminate synapses through C1q and C3 complement factors (Hong et al., <xref ref-type="bibr" rid="B200">2016</xref>). We too have reported that Aβ oligomer-mediated memory impairment is closely associated with glial activation (Balducci et al., <xref ref-type="bibr" rid="B3">2017</xref>).</p>
<p>New evidence is now shedding light on a dangerous dialogue between central immune cells and the gut, potentially leading to AD.</p>
</sec>
<sec id="s3">
<title>Microbiota-Gut-Brain Axes</title>
<p>Constant communication between the central and enteric nervous systems is required to maintain body homeostasis. This complex interplay, the “Gut-brain-axis,” is mediated by neural, endocrine and immune signals (Carabotti et al., <xref ref-type="bibr" rid="B12">2015</xref>). GM, the dense population of bacteria, viruses, fungi, and protozoa inhabiting the human gut, is now recognized as an important part of this interaction and the new term Microbiota-Gut-Brain axis, has been introduced. Recent progress in high-throughput analyses has permitted to study more in-depth the microbial composition and appreciate its complexity (Rooks and Garrett, <xref ref-type="bibr" rid="B68">2016</xref>).</p>
<p>Every person has a distinct and widely variable GM, with some common features emerging only at higher level of organization (Tremaroli and Bäckhed, <xref ref-type="bibr" rid="B86">2012</xref>). This dynamic system is subject to re-modeling in response to aging, environmental perturbations, changes in lifestyle and diet and it is therefore prone to maladaptive modifications (Santoro et al., <xref ref-type="bibr" rid="B70">2018</xref>). Substantial shifts in human GM composition have been observed in CNS disorders such as depression, anxiety, autism (Finegold et al., <xref ref-type="bibr" rid="B21">2012</xref>; Liang et al., <xref ref-type="bibr" rid="B49">2018</xref>) and neurodegeneration (Fung et al., <xref ref-type="bibr" rid="B29">2017</xref>).</p>
</sec>
<sec id="s4">
<title>Gut Microbiota in CNS Physiology</title>
<p>Germ free (GF) and antibiotic-treated rodents provided the necessary tool to study the impact of intestinal microbes on CNS development and physiology.</p>
<p>A pioneering study used GF mice, which are generated and raised in sterile conditions, to investigate the influence of GM on hypothalamic-pituitary-adrenal (HPA) response to stress. The HPA response was significantly higher in GF relative to mice raised with normal GM. The introduction of the complex microbiota at an early stage (up to 9 weeks old), could partially reverse this enhanced HPA response to stress. GF mice also had lower brain-derived neurotrophic factor (BDNF) expression, which is important for neuronal growth and synaptic plasticity, in the cortex and hippocampus (Sudo et al., <xref ref-type="bibr" rid="B82">2004</xref>).</p>
<p>Subsequent studies showed that the absence of complex microbiota has profound effects on adult behavior and CNS development and that the timing and duration of exposure to microorganisms are critical. GF condition altered spatial, working and reference memory, increased motor activity and reduced anxiety (Diaz Heijtz et al., <xref ref-type="bibr" rid="B34">2011</xref>; Gareau et al., <xref ref-type="bibr" rid="B30">2011</xref>). It also impaired hippocampal development and morphology, increased dorsal hippocampal neurogenesis and BBB permeability, and significantly altered levels of noradrenaline, dopamine and serotonin (Braniste et al., <xref ref-type="bibr" rid="B10">2014</xref>; Luczynski et al., <xref ref-type="bibr" rid="B52">2016</xref>; Sharon et al., <xref ref-type="bibr" rid="B74">2016</xref>; Lin et al., <xref ref-type="bibr" rid="B51">2018</xref>).</p>
</sec>
<sec id="s5">
<title>Symbiotic Relationship Between the Immune System and GM</title>
<p>The microbial ecosystem co-evolved with our immune system over millennia and host-specific antimicrobial peptides and pattern recognition receptors evolved not only to protect against pathogens but also to promote resident beneficial microbes (Bosch, <xref ref-type="bibr" rid="B8">2014</xref>). The immune system closely controls the GM composition and distribution (Sigal and Meyer, <xref ref-type="bibr" rid="B78">2016</xref>), while the microbial symbionts regulate immune system maturation and function (Belkaid and Hand, <xref ref-type="bibr" rid="B4">2014</xref>). Commensal GM can profoundly affect both innate and adaptive immune systems. Several studies have confirmed the interaction between microbiota and various immune cell populations: peripheral T cells, myeloid cells and mast cells (Round and Mazmanian, <xref ref-type="bibr" rid="B69">2009</xref>; Kamada et al., <xref ref-type="bibr" rid="B39">2013</xref>; Forsythe, <xref ref-type="bibr" rid="B24">2016</xref>).</p>
<p>Khosravi et al. (<xref ref-type="bibr" rid="B43">2014</xref>) provided evidence that GM influences the development of the immune system by regulating hematopoiesis of primary immune cells. They showed that GF mice have lower proportions and less differentiation potential of myeloid cell progenitors of both yolk sac and bone marrow origin. This could help explain the widespread effects of GM on the immune system, microglia included.</p>
</sec>
<sec id="s6">
<title>GM-Microglia Interaction</title>
<p>Mounting evidence from animal studies demonstrates that GM regulates microglial maturation and function. Microglia from GF or antibiotic-treated mice had an immature profile and impaired immune response (Erny et al., <xref ref-type="bibr" rid="B17">2015</xref>). The absence of gut flora altered microglia mRNA profiles and downregulated several microglial genes involved in cell activation, pathogen recognition and host defense. The microglia transcription and survival factors SFPI1 and CSF1R, normally downregulated in mature adult microglia, were upregulated in GF mice (Kierdorf and Prinz, <xref ref-type="bibr" rid="B44">2013</xref>). Matcovitch-Natan et al. (<xref ref-type="bibr" rid="B56">2016</xref>) examined the transcriptional profiles of different microglial development stages, showing that the genes related to the adult phase of microglial maturation and immune response are dysregulated in GF mice.</p>
<p>Products derived from bacterial metabolism such as short-chain fatty acids (SCFAs) were identified as key mediators of GM-microglia interaction. These molecules are able to translocate from colonic mucosa to systemic circulation (Schönfeld and Wojtczak, <xref ref-type="bibr" rid="B73">2016</xref>), cross the BBB and affect CNS function (Borre et al., <xref ref-type="bibr" rid="B7">2014</xref>). A SCFA supplement in drinking water of GF mice for 4 weeks restored many aspects of the immature microglial morphology, re-established microglial density and normalized CSF1R surface expression (Erny et al., <xref ref-type="bibr" rid="B17">2015</xref>).</p>
<p>From the therapeutic perspective, it is important to highlight that the GM-microglia interaction is highly dynamic as many of the defects observed in microglia of GF mice could be partially restored by recolonization with conventional GM or SCFA supplementation.</p>
</sec>
<sec id="s7">
<title>GM Alterations in AD</title>
<p>An association between gut dysbiosis and neurodegeneration is mostly supported by pre-clinical studies, while the clinical data are still limited. The most consistent clinical evidence of deviation from the healthy microbial composition in a neurodegenerative condition derives from studies of Parkinson’s disease (PD) patients (Keshavarzian et al., <xref ref-type="bibr" rid="B42">2015</xref>; Scheperjans et al., <xref ref-type="bibr" rid="B72">2015</xref>; Hopfner et al., <xref ref-type="bibr" rid="B36">2017</xref>). Only few studies have investigated GM populations in AD patients. Microbial diversity was reduced in AD patient feces compared to age- and sex-matched controls. At the phylum level, there was a decrease in the numbers of Firmicutes and Actinobacteria and an increase in abundance of Bacteroidetes. The relative abundance of bacterial genera correlated with the levels of cerebrospinal fluid biomarkers of AD (Vogt et al., <xref ref-type="bibr" rid="B88">2017</xref>). A recent study examined the link between selected bacterial taxa and brain amyloidosis in patients with cognitive impairment. Amyloid deposition was associated with an increased stool content of the pro-inflammatory taxa <italic>Escherichia/Shigella</italic> and low anti-inflammatory taxon <italic>Eubacterium rectale</italic>. These changes correlated well with a peripheral inflammatory state (Cattaneo et al., <xref ref-type="bibr" rid="B13">2017</xref>). A few human studies have also linked dysbioses of oro-nasal cavity microbiota with neurodegeneration (Kamer et al., <xref ref-type="bibr" rid="B40">2008</xref>; Cockburn et al., <xref ref-type="bibr" rid="B14">2012</xref>).</p>
<p>In AD animal models was found a significant shift in the composition of GM, and microbial manipulations could affect disease outcomes as summarized in <xref ref-type="fig" rid="F1">Figure 1</xref> (Brandscheid et al., <xref ref-type="bibr" rid="B9">2017</xref>; Harach et al., <xref ref-type="bibr" rid="B33">2017</xref>; Shen et al., <xref ref-type="bibr" rid="B75">2017</xref>). A combination of broad-spectrum antibiotics or GF condition in AD mice reduced Aβ plaques and attenuated plaque-surrounding glial reactivity and the levels of circulating cytokines and chemokines (Minter et al., <xref ref-type="bibr" rid="B59">2016</xref>). Conversely, re-introduction of conventionally raised AD mice gut flora in GF mice increased Aβ pathology (Harach et al., <xref ref-type="bibr" rid="B33">2017</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>Mouse models of gut microbiota (GM) manipulation. The figure illustrates the typical mouse phenotypes resulting from various GM manipulations.</p>
</caption>
<graphic xlink:href="fnagi-11-00284-g0001"></graphic>
</fig>
</sec>
<sec id="s8">
<title>How Changes in Microbial Composition Could Be Relevant to AD</title>
<p>A plethora of hypotheses have been advanced to explain possible mechanisms linking GM alteration to neurodegenerative processes, many of them involving neuroinflammation as a common driving force.</p>
<p>The GM is a major source of the bacterial surface lipopolysaccharide (LPS) and other pro-inflammatory molecules and endotoxins. AD patient’s brains contain more frequently pathogenic bacteria and LPS compared to controls (Itzhaki et al., <xref ref-type="bibr" rid="B38">2004</xref>; Fox et al., <xref ref-type="bibr" rid="B25">2019</xref>). LPS was found in the hippocampus and cortex and at higher concentrations in plasma than in healthy controls (Zhao et al., <xref ref-type="bibr" rid="B99">2017</xref>; Kowalski and Mulak, <xref ref-type="bibr" rid="B45">2019</xref>). In addition, LPS co-localizes with Aβ<sub>1–40/42</sub> in amyloid plaques and around blood vessels (Zhan et al., <xref ref-type="bibr" rid="B97">2016</xref>). Bacterial LPS can bind to microglial receptors (TLR2, TLR4 and CD14) and trigger an inflammatory response. In a recent study LPS was able to strongly activate the NF-kB (p50/p60) complex, an important initiator for neuroinflammatory processes occurring in AD (Lukiw, <xref ref-type="bibr" rid="B53">2016</xref>; Lin et al., <xref ref-type="bibr" rid="B51">2018</xref>).</p>
<p>The most common form of AD typically affects elderly people and aging is associated with significant changes in GM composition. These age-related changes are mainly due to modifications in life-style, diet and a chronic low-grade inflammatory state called “inflammaging” (Santoro et al., <xref ref-type="bibr" rid="B70">2018</xref>). GM in the elderly is reduced in diversity and stability and is less resistant to environmental perturbations such as stress and antibiotics (Biagi et al., <xref ref-type="bibr" rid="B5">2010</xref>). Therefore, it is more vulnerable to the invasion of opportunistic species and to clinically important changes in microbial composition. It has been shown that implantation of aged GM in young GF mice induced inflammaging. In addition, the aged GM promoted small intestine inflammation in implanted GF mice and weakened the intestinal barrier making possible the infiltration of inflammatory bacterial components into the circulation. An increase in systemic T cell activation was also observed (Fransen et al., <xref ref-type="bibr" rid="B26">2017</xref>). In humans, there is an age-related decline in immune system function (Fulop et al., <xref ref-type="bibr" rid="B28">2018</xref>), that could make gut dysbiosis more relevant in triggering low-grade systemic inflammation.</p>
<p>A recent study in mice lacking PINK1<sup>−/−</sup>, which has a key role in adaptive immunity by repressing presentation of mitochondrial antigens, suggests that specific deficits in the immune system function could make intestinal infection a risk factor for neurodegeneration. In these mice, gut infection triggered an autoimmune mechanism involving the mitochondria specific CD8<sup>+</sup> cells, which are toxic for both peripheral and central neurons. These events led to the degeneration of dopaminergic neurons and motor symptoms typical of PD (Matheoud et al., <xref ref-type="bibr" rid="B57">2019</xref>).</p>
<p>In animal models, dysbiosis increases gut permeability and promotes inflammation and macrophage dysfunction (Thevaranjan et al., <xref ref-type="bibr" rid="B84">2018</xref>). There is evidence of BBB damage and accumulation of blood-derived products in AD brains (Kowalski and Mulak, <xref ref-type="bibr" rid="B45">2019</xref>). The passage of harmful agents from the gut to the brain is still not adequately explained, but compromised the integrity of epithelial barriers might play a role (Sochocka et al., <xref ref-type="bibr" rid="B79">2019</xref>).</p>
<p>Several gut bacterial species such as <italic>E. coli, Salmonella</italic> and <italic>Citrobacter</italic> produce Aβ (O’Toole et al., <xref ref-type="bibr" rid="B61">2000</xref>; Zhou et al., <xref ref-type="bibr" rid="B100">2012</xref>). Amyloids are common structural components of the extracellular matrix in which bacterial cells stay close to each other. Exposure to microbial amyloids might trigger amyloid misfolding in the brain. Increasing evidence supports the idea that the formation and propagation of Aβ seeds is a prion-like mechanism (Walker et al., <xref ref-type="bibr" rid="B90">2016</xref>). However, it is still not clear how bacterial amyloids could gain access to the brain. One possibility is uptake through specialized epithelial cells of the mucosa-associated lymphoid tissues, then physical interaction between enteric nervous system fibers and parasympathetic neurons of vagusnerve where they could reach the CNS <italic>via</italic> retrograde axonal transport (Kujala et al., <xref ref-type="bibr" rid="B47">2011</xref>; Friedland and Chapman, <xref ref-type="bibr" rid="B27">2017</xref>). The key study supporting the hypotheses that the spread of misfolded proteins from the gut to the brain could occur <italic>via</italic> the vagus nerve comes from the context of α-synuclein propagation in PD (Ulusoy et al., <xref ref-type="bibr" rid="B87">2015</xref>; Breen et al., <xref ref-type="bibr" rid="B11">2019</xref>; Santos et al., <xref ref-type="bibr" rid="B71">2019</xref>).</p>
<p>Soscia et al., in 2010 noticed some interesting similarities in biophysical properties of Aβ and a family of biomolecules called “antimicrobial peptides” (AMPs). AMPs are potent broad spectrum antibiotics and modulators of immune system in the brain and other immune-privileged tissues. Dysregulation of these molecules can lead to neurotoxicity and chronic inflammation (Soscia et al., <xref ref-type="bibr" rid="B81">2010</xref>). This study, followed by few others, confirmed the antimicrobial properties of Aβ and proposed its possible physiological role in brain’s innate immune response to microbes. They advanced the hypotheses that brain infiltration of gut bacteria or their components might stimulate Aβ production and deposition (White et al., <xref ref-type="bibr" rid="B94">2014</xref>; Kumar et al., <xref ref-type="bibr" rid="B48">2016</xref>; Eimer et al., <xref ref-type="bibr" rid="B16">2018</xref>).</p>
<p><xref ref-type="fig" rid="F2">Figure 2</xref> summarizes the possible pathological events increasing the risk of AD as a consequence of GM dysbiosis.</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<p>From gut dysbiosis to Alzheimer’s disease (AD). The figure depicts the possible pathological events associated with gut dysbiosis leading to both peripheral and central pathological events which would increase the risk of AD.</p>
</caption>
<graphic xlink:href="fnagi-11-00284-g0002"></graphic>
</fig>
</sec>
<sec id="s9">
<title>Therapeutic Potential of Microbiota in Neuroinflammation and AD</title>
<p>At present, the existing data on the mechanisms linking GM to neurodegeneration, mostly based on animal studies, are still not sufficient to provide directions for the development of GM-based therapeutic strategies.</p>
<p>Attempts to use probiotics were made mostly in animal models, although there is no evidence that this approach can lead to long-term alterations in GM composition (Akbari et al., <xref ref-type="bibr" rid="B1">2016</xref>; Musa et al., <xref ref-type="bibr" rid="B60">2017</xref>; Plaza-Díaz et al., <xref ref-type="bibr" rid="B65">2017</xref>; Kowalski and Mulak, <xref ref-type="bibr" rid="B45">2019</xref>). In one clinical trial, PD patients were given antibiotics to treat small intestinal bacterial overgrowth, with improvements in gastrointestinal symptoms and motor fluctuations (Fasano et al., <xref ref-type="bibr" rid="B19">2013</xref>). Another strategy for modifying GM composition is fecal transplant, already successful for treating infections of <italic>Clostridium difficile</italic> (Xu et al., <xref ref-type="bibr" rid="B96">2015</xref>), but there are only limited attempts to use it outside gastrointestinal diseases (Evrensel and Ceylan, <xref ref-type="bibr" rid="B18">2016</xref>).</p>
<p>Pre-clinical evidence suggests that microbial metabolism products such as SCFAs could be signaling molecules used by gut microbes to act on the CNS (Erny et al., <xref ref-type="bibr" rid="B17">2015</xref>). Their interaction with the immune system and anti-inflammatory properties make them interesting therapeutic candidates for neurodegenerative disorders. Several strategies for delivery of SCFAs are summarized in Gill et al. (<xref ref-type="bibr" rid="B31">2018</xref>).</p>
<p>To date, dietary and lifestyle modifications are the most effective way to produce long-term changes in GM. Some healthy dietary patterns such as Mediterranean, Japanese or FINGER (Finish Geriatric intervention study) diet can positively influence the rates of cognitive decline (Pistollato et al., <xref ref-type="bibr" rid="B64">2018</xref>; Wahl et al., <xref ref-type="bibr" rid="B89">2019</xref>) and also induce significant changes in GM composition.</p>
<p>Among the most significant examples of nutritional intervention with neuroprotective and age-delaying potential is caloric restriction (CR) which can be obtained by reducing the daily caloric intake or by intermittent fasting (Fontana, <xref ref-type="bibr" rid="B22">2018</xref>). CR delays the onset of neurodegeneration in rodents and prevents several hallmarks of brain aging in non-human primates and humans (Pani, <xref ref-type="bibr" rid="B202">2015</xref>). The possible underlying mechanisms are numerous and reviewed in Zullo et al. (<xref ref-type="bibr" rid="B101">2018</xref>). Briefly, CR increases levels of neuroprotective factors while decreasing oxidative stress, inflammation, and activity of pro-apoptotic factors (Maalouf et al., <xref ref-type="bibr" rid="B54">2009</xref>). At a molecular level, CR acts on nutrient-sensing pathways through different mechanisms. Notably, it can activate the SIRT1 enzyme (a member of the sirtuin family that regulates gene expression) which downregulates the mammalian target of rapamycin (mTOR), thus suppressing NF-kB-dependent neuroinflammation and inducing autophagy as neuronal self-defense mechanism (Maalouf et al., <xref ref-type="bibr" rid="B54">2009</xref>; Shirooie et al., <xref ref-type="bibr" rid="B76">2018</xref>).</p>
<p>Fasting can induce rapid adaptations in GM composition favoring growth of beneficial and anti-inflammatory microbial phylotypes and lead to significant changes in the SCFA biosynthesis (Zhang et al., <xref ref-type="bibr" rid="B98">2013</xref>; Tanca et al., <xref ref-type="bibr" rid="B83">2018</xref>). GM interacts with several mechanisms of metabolic response to nutrient deprivation. For instance, SIRT1 activation regulates, the GM resulting in lower intestinal inflammation during aging (Wellman et al., <xref ref-type="bibr" rid="B92">2017</xref>). Some substances such as resveratrol, a natural phenol found in grapes and red wine can activate, in alternative to CR, the sirtuine pathway (Kelly, <xref ref-type="bibr" rid="B41">2010</xref>) and positively influence GM. The interaction between resveratrol and GM is bidirectional as gut microbes affect also resveratrol bioavailability (Hu et al., <xref ref-type="bibr" rid="B37">2019</xref>).</p>
<p>CR shares some common metabolic effects with the ketogenic diet (KD) which is high in fat, moderate in proteins and very low in carbohydrate. KD is already used to treat patients with drug resistant epilepsy (Stafstrom and Rho, <xref ref-type="bibr" rid="B201">2012</xref>) and in a few studies have revealed the potential to reduce symptoms of neurodegeneration (Włodarek, <xref ref-type="bibr" rid="B95">2019</xref>). Remarkably, a study using mouse models of drug-resistant epilepsy showed that the KD anti-seizure properties were mediated by microbiota. Depletion of GM with a high dose antibiotic treatment abolished the KD beneficial effects (Olson et al., <xref ref-type="bibr" rid="B62">2018</xref>).</p>
<p>Among other modifiable factors, exercise is considered to promote diversity and enhance beneficial metabolic functions of microbial species in the gut and improve cognitive performance (Ticinesi et al., <xref ref-type="bibr" rid="B85">2019</xref>).</p>
<p>A preventive therapy based on changes in diet and levels of physical activity seems to be the most promising approach for delaying cognitive decline and improving metabolic, neuroendocrine and vascular abnormalities that often precede and likely significantly contribute to cognitive deterioration (Sohn, <xref ref-type="bibr" rid="B80">2018</xref>). A successful preventive strategy must recognize that GM is an important mediator of the effects of diet and exercise on cognitive decline, aging and inflammation. However, additional studies are needed to understand if dietary interventions, such as CR, could be safely recommended to elderly population, which is already at risk of malnutrition and sarcopenia (Sieber, <xref ref-type="bibr" rid="B77">2019</xref>).</p>
<p>One of the present difficulties in tailoring a GM-based therapy is its inter-individual variability in composition and metabolism, but with the rapid advancement in research and diagnostic technologies a new type of personalized medicine might well become possible.</p>
</sec>
<sec id="s10">
<title>GM and AD Development: Main Experimental Limitations</title>
<p>Although the study of microbiota-gut-brain axis in recent years has flourished, there are still many obstacles. For instance, a lack of well-defined methodological standards make it hard to compare studies and numerous confounding factors including diet, drugs and concomitant pathologies must be carefully considered in the analysis (Marizzoni et al., <xref ref-type="bibr" rid="B55">2017</xref>). One of the key questions that need to be addressed is whether changes in GM are cause or secondary effects of the disease. At present, GF and antibiotic-treated rodents remain the best available tools for transitioning from observational studies to understanding the cause-effect directionality. However, the translational value of studies of human microbiota in rodent models is limited by obvious differences in diet and microbiota composition.</p>
</sec>
<sec id="s11">
<title>Author Contributions</title>
<p>MC and CB wrote the manuscript. GF revised the manuscript.</p>
</sec>
<sec id="s12">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack>
<p>We thank our English editor Judith Baggott for language revision.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akbari</surname><given-names>E.</given-names></name><name><surname>Asemi</surname><given-names>Z.</given-names></name><name><surname>Daneshvar Kakhaki</surname><given-names>R.</given-names></name><name><surname>Bahmani</surname><given-names>F.</given-names></name><name><surname>Kouchaki</surname><given-names>E.</given-names></name><name><surname>Tamtaji</surname><given-names>O. R.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer’s disease: a randomized, double-blind and controlled trial</article-title>. <source/>Front. Aging Neurosci.
<volume>8</volume>:<fpage>256</fpage>. <pub-id pub-id-type="doi">10.3389/fnagi.2016.00256</pub-id><pub-id pub-id-type="pmid">27891089</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balducci</surname><given-names>C.</given-names></name><name><surname>Forloni</surname><given-names>G.</given-names></name></person-group> (<year>2018</year>). <article-title>Novel targets in Alzheimer’s disease: a special focus on microglia</article-title>. <source/>Pharmacol. Res.
<volume>130</volume>, <fpage>402</fpage>–<lpage>413</lpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2018.01.017</pub-id><pub-id pub-id-type="pmid">29391235</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balducci</surname><given-names>C.</given-names></name><name><surname>Frasca</surname><given-names>A.</given-names></name><name><surname>Zotti</surname><given-names>M.</given-names></name><name><surname>La Vitola</surname><given-names>P.</given-names></name><name><surname>Mhillaj</surname><given-names>E.</given-names></name><name><surname>Grigoli</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Toll-like receptor 4-dependent glial cell activation mediates the impairment in memory establishment induced by β-amyloid oligomers in an acute mouse model of Alzheimer’s disease</article-title>. <source/>Brain Behav. Immun.
<volume>60</volume>, <fpage>188</fpage>–<lpage>197</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2016.10.012</pub-id><pub-id pub-id-type="pmid">27751869</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belkaid</surname><given-names>Y.</given-names></name><name><surname>Hand</surname><given-names>T. W.</given-names></name></person-group> (<year>2014</year>). <article-title>Role of the microbiota in immunity and inflammation</article-title>. <source/>Cell
<volume>157</volume>, <fpage>121</fpage>–<lpage>141</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2014.03.011</pub-id><pub-id pub-id-type="pmid">24679531</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biagi</surname><given-names>E.</given-names></name><name><surname>Nylund</surname><given-names>L.</given-names></name><name><surname>Candela</surname><given-names>M.</given-names></name><name><surname>Ostan</surname><given-names>R.</given-names></name><name><surname>Bucci</surname><given-names>L.</given-names></name><name><surname>Pini</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Through ageing and beyond: gut microbiota and inflammatory status in seniors and centenarians</article-title>. <source/>PLoS One
<volume>5</volume>:<fpage>e10667</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0010667</pub-id><pub-id pub-id-type="pmid">20498852</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonham</surname><given-names>L. W.</given-names></name><name><surname>Sirkis</surname><given-names>D. W.</given-names></name><name><surname>Yokoyama</surname><given-names>J. S.</given-names></name></person-group> (<year>2019</year>). <article-title>The transcriptional landscape of microglial genes in aging and neurodegenerative disease</article-title>. <source/>Front. Immunol.
<volume>10</volume>:<fpage>1170</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2019.01170</pub-id><pub-id pub-id-type="pmid">31214167</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borre</surname><given-names>Y. E.</given-names></name><name><surname>O’Keeffe</surname><given-names>G. W.</given-names></name><name><surname>Clarke</surname><given-names>G.</given-names></name><name><surname>Stanton</surname><given-names>C.</given-names></name><name><surname>Dinan</surname><given-names>T. G.</given-names></name><name><surname>Cryan</surname><given-names>J. F.</given-names></name></person-group> (<year>2014</year>). <article-title>Microbiota and neurodevelopmental windows: implications for brain disorders</article-title>. <source/>Trends Mol. Med.
<volume>20</volume>, <fpage>509</fpage>–<lpage>518</lpage>. <pub-id pub-id-type="doi">10.1016/j.molmed.2014.05.002</pub-id><pub-id pub-id-type="pmid">24956966</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosch</surname><given-names>T. C. G.</given-names></name></person-group> (<year>2014</year>). <article-title>Rethinking the role of immunity: lessons from Hydra</article-title>. <source/>Trends Immunol.
<volume>35</volume>, <fpage>495</fpage>–<lpage>502</lpage>. <pub-id pub-id-type="doi">10.1016/j.it.2014.07.008</pub-id><pub-id pub-id-type="pmid">25174994</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brandscheid</surname><given-names>C.</given-names></name><name><surname>Schuck</surname><given-names>F.</given-names></name><name><surname>Reinhardt</surname><given-names>S.</given-names></name><name><surname>Schäfer</surname><given-names>K.-H.</given-names></name><name><surname>Pietrzik</surname><given-names>C. U.</given-names></name><name><surname>Grimm</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Altered gut microbiome composition and tryptic activity of the 5xFAD Alzheimer’s mouse model</article-title>. <source/>J. Alzheimers Dis.
<volume>56</volume>, <fpage>775</fpage>–<lpage>788</lpage>. <pub-id pub-id-type="doi">10.3233/jad-160926</pub-id><pub-id pub-id-type="pmid">28035935</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braniste</surname><given-names>V.</given-names></name><name><surname>Al-Asmakh</surname><given-names>M.</given-names></name><name><surname>Kowal</surname><given-names>C.</given-names></name><name><surname>Anuar</surname><given-names>F.</given-names></name><name><surname>Abbaspour</surname><given-names>A.</given-names></name><name><surname>Toth</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>The gut microbiota influences blood-brain barrier permeability in mice</article-title>. <source/>Sci. Transl. Med.
<volume>6</volume>:<fpage>263ra158</fpage>. <pub-id pub-id-type="doi">10.1126/scitranslmed.3009759</pub-id><pub-id pub-id-type="pmid">25411471</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breen</surname><given-names>D. P.</given-names></name><name><surname>Halliday</surname><given-names>G. M.</given-names></name><name><surname>Lang</surname><given-names>A. E.</given-names></name></person-group> (<year>2019</year>). <article-title>Gut-brain axis and the spread of α-synuclein pathology: vagal highway or dead end?</article-title>
<source/>Mov. Disord.
<volume>34</volume>, <fpage>307</fpage>–<lpage>316</lpage>. <pub-id pub-id-type="doi">10.1002/mds.27556</pub-id><pub-id pub-id-type="pmid">30653258</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carabotti</surname><given-names>M.</given-names></name><name><surname>Scirocco</surname><given-names>A.</given-names></name><name><surname>Maselli</surname><given-names>M. A.</given-names></name><name><surname>Severi</surname><given-names>C.</given-names></name></person-group> (<year>2015</year>). <article-title>The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems</article-title>. <source/>Ann. Gastroenterol.
<volume>28</volume>, <fpage>203</fpage>–<lpage>209</lpage>. <pub-id pub-id-type="pmid">25830558</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cattaneo</surname><given-names>A.</given-names></name><name><surname>Cattane</surname><given-names>N.</given-names></name><name><surname>Galluzzi</surname><given-names>S.</given-names></name><name><surname>Provasi</surname><given-names>S.</given-names></name><name><surname>Lopizzo</surname><given-names>N.</given-names></name><name><surname>Festari</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly</article-title>. <source/>Neurobiol. Aging
<volume>49</volume>, <fpage>60</fpage>–<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2016.08.019</pub-id><pub-id pub-id-type="pmid">27776263</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cockburn</surname><given-names>A. F.</given-names></name><name><surname>Dehlin</surname><given-names>J. M.</given-names></name><name><surname>Ngan</surname><given-names>T.</given-names></name><name><surname>Crout</surname><given-names>R.</given-names></name><name><surname>Boskovic</surname><given-names>G.</given-names></name><name><surname>Denvir</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>High throughput DNA sequencing to detect differences in the subgingival plaque microbiome in elderly subjects with and without dementia</article-title>. <source/>Investig. Genet.
<volume>3</volume>:<fpage>19</fpage>. <pub-id pub-id-type="doi">10.1186/2041-2223-3-19</pub-id><pub-id pub-id-type="pmid">22998923</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diaz Heijtz</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Anuar</surname><given-names>F.</given-names></name><name><surname>Qian</surname><given-names>Y.</given-names></name><name><surname>Bjorkholm</surname><given-names>B.</given-names></name><name><surname>Samuelsson</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Normal gut microbiota modulates brain development and behavior</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>108</volume>, <fpage>3047</fpage>–<lpage>3052</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1010529108</pub-id><pub-id pub-id-type="pmid">21282636</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dickson</surname><given-names>D. W.</given-names></name><name><surname>Lee</surname><given-names>S. C.</given-names></name><name><surname>Mattiace</surname><given-names>L. A.</given-names></name><name><surname>Yen</surname><given-names>S.-H. C.</given-names></name><name><surname>Brosnan</surname><given-names>C.</given-names></name></person-group> (<year>1993</year>). <article-title>Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer’s disease</article-title>. <source/>Glia
<volume>7</volume>, <fpage>75</fpage>–<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1002/glia.440070113</pub-id><pub-id pub-id-type="pmid">8423065</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eimer</surname><given-names>W. A.</given-names></name><name><surname>Vijaya Kumar</surname><given-names>D. K.</given-names></name><name><surname>Navalpur Shanmugam</surname><given-names>N. K.</given-names></name><name><surname>Rodriguez</surname><given-names>A. S.</given-names></name><name><surname>Mitchell</surname><given-names>T.</given-names></name><name><surname>Washicosky</surname><given-names>K. J.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Alzheimer’s disease-associated β-amyloid is rapidly seeded by herpesviridae to protect against brain infection</article-title>. <source/>Neuron
<volume>99</volume>, <fpage>56.e3</fpage>–<lpage>63.e3</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2018.06.030</pub-id><pub-id pub-id-type="pmid">30001512</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erny</surname><given-names>D.</given-names></name><name><surname>Hrabě de Angelis</surname><given-names>A. L.</given-names></name><name><surname>Jaitin</surname><given-names>D.</given-names></name><name><surname>Wieghofer</surname><given-names>P.</given-names></name><name><surname>Staszewski</surname><given-names>O.</given-names></name><name><surname>David</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Host microbiota constantly control maturation and function of microglia in the CNS</article-title>. <source/>Nat. Neurosci.
<volume>18</volume>, <fpage>965</fpage>–<lpage>977</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4030</pub-id><pub-id pub-id-type="pmid">26030851</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evrensel</surname><given-names>A.</given-names></name><name><surname>Ceylan</surname><given-names>M. E.</given-names></name></person-group> (<year>2016</year>). <article-title>Fecal microbiota transplantation and its usage in neuropsychiatric disorders</article-title>. <source/>Clin. Psychopharmacol. Neurosci.
<volume>14</volume>, <fpage>231</fpage>–<lpage>237</lpage>. <pub-id pub-id-type="doi">10.9758/cpn.2016.14.3.231</pub-id><pub-id pub-id-type="pmid">27489376</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fasano</surname><given-names>A.</given-names></name><name><surname>Bove</surname><given-names>F.</given-names></name><name><surname>Gabrielli</surname><given-names>M.</given-names></name><name><surname>Petracca</surname><given-names>M.</given-names></name><name><surname>Zocco</surname><given-names>M. A.</given-names></name><name><surname>Ragazzoni</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>The role of small intestinal bacterial overgrowth in Parkinson’s disease</article-title>. <source/>Mov. Disord.
<volume>28</volume>, <fpage>1241</fpage>–<lpage>1249</lpage>. <pub-id pub-id-type="doi">10.1002/mds.25522</pub-id><pub-id pub-id-type="pmid">23712625</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiala</surname><given-names>M.</given-names></name><name><surname>Veerhuis</surname><given-names>R.</given-names></name></person-group> (<year>2010</year>). <article-title>Biomarkers of inflammation and amyloid-β phagocytosis in patients at risk of Alzheimer disease</article-title>. <source/>Exp. Gerontol.
<volume>45</volume>, <fpage>57</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1016/j.exger.2009.08.003</pub-id><pub-id pub-id-type="pmid">19699791</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finegold</surname><given-names>S. M.</given-names></name><name><surname>Downes</surname><given-names>J.</given-names></name><name><surname>Summanen</surname><given-names>P. H.</given-names></name></person-group> (<year>2012</year>). <article-title>Microbiology of regressive autism</article-title>. <source/>Anaerobe
<volume>18</volume>, <fpage>260</fpage>–<lpage>262</lpage>. <pub-id pub-id-type="doi">10.1016/j.anaerobe.2011.12.018</pub-id><pub-id pub-id-type="pmid">22202440</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontana</surname><given-names>L.</given-names></name></person-group> (<year>2018</year>). <article-title>Interventions to promote cardiometabolic health and slow cardiovascular ageing</article-title>. <source/>Nat. Rev. Cardiol.
<volume>15</volume>, <fpage>566</fpage>–<lpage>577</lpage>. <pub-id pub-id-type="doi">10.1038/s41569-018-0026-8</pub-id><pub-id pub-id-type="pmid">29795242</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forloni</surname><given-names>G.</given-names></name><name><surname>Artuso</surname><given-names>V.</given-names></name><name><surname>La Vitola</surname><given-names>P.</given-names></name><name><surname>Balducci</surname><given-names>C.</given-names></name></person-group> (<year>2016</year>). <article-title>Oligomeropathies and pathogenesis of Alzheimer and Parkinson’s diseases</article-title>. <source/>Mov. Disord.
<volume>31</volume>, <fpage>771</fpage>–<lpage>781</lpage>. <pub-id pub-id-type="doi">10.1002/mds.26624</pub-id><pub-id pub-id-type="pmid">27030592</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forsythe</surname><given-names>P.</given-names></name></person-group> (<year>2016</year>). <article-title>Microbes taming mast cells: implications for allergic inflammation and beyond</article-title>. <source/>Eur. J. Pharmacol.
<volume>778</volume>, <fpage>169</fpage>–<lpage>175</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2015.06.034</pub-id><pub-id pub-id-type="pmid">26130124</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>M.</given-names></name><name><surname>Knorr</surname><given-names>D. A.</given-names></name><name><surname>Haptonstall</surname><given-names>K. M.</given-names></name></person-group> (<year>2019</year>). <article-title>Alzheimer’s disease and symbiotic microbiota: an evolutionary medicine perspective</article-title>. <source/>Ann. N Y Acad. Sci.
<volume>1449</volume>, <fpage>3</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1111/nyas.14129</pub-id><pub-id pub-id-type="pmid">31180143</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fransen</surname><given-names>F.</given-names></name><name><surname>van Beek</surname><given-names>A. A.</given-names></name><name><surname>Borghuis</surname><given-names>T.</given-names></name><name><surname>Aidy</surname><given-names>S. E.</given-names></name><name><surname>Hugenholtz</surname><given-names>F.</given-names></name><name><surname>van der Gaast-de Jongh</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Aged gut microbiota contributes to systemical inflammaging after transfer to germ-free mice</article-title>. <source/>Front. Immunol.
<volume>8</volume>:<fpage>1385</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2017.01385</pub-id><pub-id pub-id-type="pmid">29163474</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedland</surname><given-names>R. P.</given-names></name><name><surname>Chapman</surname><given-names>M. R.</given-names></name></person-group> (<year>2017</year>). <article-title>The role of microbial amyloid in neurodegeneration</article-title>. <source/>PLoS Pathog.
<volume>13</volume>:<fpage>e1006654</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1006654</pub-id><pub-id pub-id-type="pmid">29267402</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fulop</surname><given-names>T.</given-names></name><name><surname>Larbi</surname><given-names>A.</given-names></name><name><surname>Dupuis</surname><given-names>G.</given-names></name><name><surname>Le Page</surname><given-names>A.</given-names></name><name><surname>Frost</surname><given-names>E. H.</given-names></name><name><surname>Cohen</surname><given-names>A. A.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Immunosenescence and inflamm-aging as two sides of the same coin: friends or foes?</article-title>
<source/>Front. Immunol.
<volume>8</volume>:<fpage>1960</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2017.01960</pub-id><pub-id pub-id-type="pmid">29375577</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fung</surname><given-names>T. C.</given-names></name><name><surname>Olson</surname><given-names>C. A.</given-names></name><name><surname>Hsiao</surname><given-names>E. Y.</given-names></name></person-group> (<year>2017</year>). <article-title>Interactions between the microbiota, immune and nervous systems in health and disease</article-title>. <source/>Nat. Neurosci.
<volume>20</volume>, <fpage>145</fpage>–<lpage>155</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4476</pub-id><pub-id pub-id-type="pmid">28092661</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gareau</surname><given-names>M. G.</given-names></name><name><surname>Wine</surname><given-names>E.</given-names></name><name><surname>Rodrigues</surname><given-names>D. M.</given-names></name><name><surname>Cho</surname><given-names>J. H.</given-names></name><name><surname>Whary</surname><given-names>M. T.</given-names></name><name><surname>Philpott</surname><given-names>D. J.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Bacterial infection causes stress-induced memory dysfunction in mice</article-title>. <source/>Gut
<volume>60</volume>, <fpage>307</fpage>–<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1136/gut.2009.202515</pub-id><pub-id pub-id-type="pmid">20966022</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gill</surname><given-names>P. A.</given-names></name><name><surname>van Zelm</surname><given-names>M. C.</given-names></name><name><surname>Muir</surname><given-names>J. G.</given-names></name><name><surname>Gibson</surname><given-names>P. R.</given-names></name></person-group> (<year>2018</year>). <article-title>Review article: short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders</article-title>. <source/>Aliment. Pharmacol. Ther.
<volume>48</volume>, <fpage>15</fpage>–<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1111/apt.14689</pub-id><pub-id pub-id-type="pmid">29722430</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffin</surname><given-names>W. S.</given-names></name><name><surname>Stanley</surname><given-names>L. C.</given-names></name><name><surname>Ling</surname><given-names>C.</given-names></name><name><surname>White</surname><given-names>L.</given-names></name><name><surname>MacLeod</surname><given-names>V.</given-names></name><name><surname>Perrot</surname><given-names>L. J.</given-names></name><etal></etal></person-group>. (<year>1989</year>). <article-title>Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>86</volume>, <fpage>7611</fpage>–<lpage>7615</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.86.19.7611</pub-id><pub-id pub-id-type="pmid">2529544</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harach</surname><given-names>T.</given-names></name><name><surname>Marungruang</surname><given-names>N.</given-names></name><name><surname>Duthilleul</surname><given-names>N.</given-names></name><name><surname>Cheatham</surname><given-names>V.</given-names></name><name><surname>Mc Coy</surname><given-names>K. D.</given-names></name><name><surname>Frisoni</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Reduction of Aβ amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota</article-title>. <source/>Sci. Rep.
<volume>7</volume>:<fpage>46856</fpage>. <pub-id pub-id-type="doi">10.1038/srep46856</pub-id><pub-id pub-id-type="pmid">28691712</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heneka</surname><given-names>M. T.</given-names></name><name><surname>Carson</surname><given-names>M. J.</given-names></name><name><surname>Khoury</surname><given-names>J. E.</given-names></name><name><surname>Landreth</surname><given-names>G. E.</given-names></name><name><surname>Brosseron</surname><given-names>F.</given-names></name><name><surname>Feinstein</surname><given-names>D. L.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Neuroinflammation in Alzheimer’s disease</article-title>. <source/>Lancet Neurol.
<volume>14</volume>, <fpage>388</fpage>–<lpage>405</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(15)70016-5</pub-id><pub-id pub-id-type="pmid">25792098</pub-id></mixed-citation>
</ref>
<ref id="B200">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>S.</given-names></name><name><surname>Beja-Glasser</surname><given-names>V. F.</given-names></name><name><surname>Nfonoyim</surname><given-names>B. M.</given-names></name><name><surname>Frouin</surname><given-names>A.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Ramakrishnan</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Complement and microglia mediate early synapse loss in Alzheimer mouse models</article-title>. <source/>Science
<volume>352</volume>, <fpage>712</fpage>–<lpage>716</lpage>. <pub-id pub-id-type="doi">10.1126/science.aad8373</pub-id><pub-id pub-id-type="pmid">27033548</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hopfner</surname><given-names>F.</given-names></name><name><surname>Künstner</surname><given-names>A.</given-names></name><name><surname>Müller</surname><given-names>S. H.</given-names></name><name><surname>Künzel</surname><given-names>S.</given-names></name><name><surname>Zeuner</surname><given-names>K. E.</given-names></name><name><surname>Margraf</surname><given-names>N. G.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Gut microbiota in Parkinson disease in a northern German cohort</article-title>. <source/>Brain Res.
<volume>1667</volume>, <fpage>41</fpage>–<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2017.04.019</pub-id><pub-id pub-id-type="pmid">28506555</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>D.</given-names></name><name><surname>Zheng</surname><given-names>P.</given-names></name><name><surname>Yu</surname><given-names>J.</given-names></name><name><surname>He</surname><given-names>J.</given-names></name><name><surname>Mao</surname><given-names>X.</given-names></name><etal></etal></person-group>. (<year>2019</year>). <article-title>The bidirectional interactions between resveratrol and gut microbiota: an insight into oxidative stress and inflammatory bowel disease therapy</article-title>. <source/>Biomed Res. Int.
<volume>2019</volume>:<fpage>5403761</fpage>. <pub-id pub-id-type="doi">10.1155/2019/5403761</pub-id><pub-id pub-id-type="pmid">31179328</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Itzhaki</surname><given-names>R. F.</given-names></name><name><surname>Wozniak</surname><given-names>M. A.</given-names></name><name><surname>Appelt</surname><given-names>D. M.</given-names></name><name><surname>Balin</surname><given-names>B. J.</given-names></name></person-group> (<year>2004</year>). <article-title>Infiltration of the brain by pathogens causes Alzheimer’s disease</article-title>. <source/>Neurobiol. Aging
<volume>25</volume>, <fpage>619</fpage>–<lpage>627</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2003.12.021</pub-id><pub-id pub-id-type="pmid">15172740</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamada</surname><given-names>N.</given-names></name><name><surname>Seo</surname><given-names>S.-U.</given-names></name><name><surname>Chen</surname><given-names>G. Y.</given-names></name><name><surname>Núñez</surname><given-names>G.</given-names></name></person-group> (<year>2013</year>). <article-title>Role of the gut microbiota in immunity and inflammatory disease</article-title>. <source/>Nat. Rev. Immunol.
<volume>13</volume>, <fpage>321</fpage>–<lpage>335</lpage>. <pub-id pub-id-type="doi">10.1038/nri3430</pub-id><pub-id pub-id-type="pmid">23618829</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamer</surname><given-names>A. R.</given-names></name><name><surname>Dasanayake</surname><given-names>A. P.</given-names></name><name><surname>Craig</surname><given-names>R. G.</given-names></name><name><surname>Glodzik-Sobanska</surname><given-names>L.</given-names></name><name><surname>Bry</surname><given-names>M.</given-names></name><name><surname>de Leon</surname><given-names>M. J.</given-names></name></person-group> (<year>2008</year>). <article-title>Alzheimer’s disease and peripheral infections: the possible contribution from periodontal infections, model and hypothesis</article-title>. <source/>J. Alzheimers Dis.
<volume>13</volume>, <fpage>437</fpage>–<lpage>449</lpage>. <pub-id pub-id-type="doi">10.3233/jad-2008-13408</pub-id><pub-id pub-id-type="pmid">18487851</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>G.</given-names></name></person-group> (<year>2010</year>). <article-title>A review of the sirtuin system, its clinical implications and the potential role of dietary activators like resveratrol: part 1</article-title>. <source/>Altern. Med. Rev.
<volume>15</volume>, <fpage>245</fpage>–<lpage>263</lpage>. <pub-id pub-id-type="pmid">21155626</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keshavarzian</surname><given-names>A.</given-names></name><name><surname>Green</surname><given-names>S. J.</given-names></name><name><surname>Engen</surname><given-names>P. A.</given-names></name><name><surname>Voigt</surname><given-names>R. M.</given-names></name><name><surname>Naqib</surname><given-names>A.</given-names></name><name><surname>Forsyth</surname><given-names>C. B.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Colonic bacterial composition in Parkinson’s disease</article-title>. <source/>Mov. Disord.
<volume>30</volume>, <fpage>1351</fpage>–<lpage>1360</lpage>. <pub-id pub-id-type="doi">10.1002/mds.26307</pub-id><pub-id pub-id-type="pmid">26179554</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khosravi</surname><given-names>A.</given-names></name><name><surname>Yáñez</surname><given-names>A.</given-names></name><name><surname>Price</surname><given-names>J. G.</given-names></name><name><surname>Chow</surname><given-names>A.</given-names></name><name><surname>Merad</surname><given-names>M.</given-names></name><name><surname>Goodridge</surname><given-names>H. S.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Gut microbiota promote hematopoiesis to control bacterial infection</article-title>. <source/>Cell Host Microbe
<volume>15</volume>, <fpage>374</fpage>–<lpage>381</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2014.02.006</pub-id><pub-id pub-id-type="pmid">24629343</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kierdorf</surname><given-names>K.</given-names></name><name><surname>Prinz</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Factors regulating microglia activation</article-title>. <source/>Front. Cell. Neurosci.
<volume>7</volume>:<fpage>44</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2013.00044</pub-id><pub-id pub-id-type="pmid">23630462</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kowalski</surname><given-names>K.</given-names></name><name><surname>Mulak</surname><given-names>A.</given-names></name></person-group> (<year>2019</year>). <article-title>Brain-gut-microbiota axis in Alzheimer’s disease</article-title>. <source/>J. Neurogastroenterol. Motil.
<volume>25</volume>, <fpage>48</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.5056/jnm18087</pub-id><pub-id pub-id-type="pmid">30646475</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krabbe</surname><given-names>G.</given-names></name><name><surname>Halle</surname><given-names>A.</given-names></name><name><surname>Matyash</surname><given-names>V.</given-names></name><name><surname>Rinnenthal</surname><given-names>J. L.</given-names></name><name><surname>Eom</surname><given-names>G. D.</given-names></name><name><surname>Bernhardt</surname><given-names>U.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Functional impairment of microglia coincides with β-amyloid deposition in mice with Alzheimer-like pathology</article-title>. <source/>PLoS One
<volume>8</volume>:<fpage>e60921</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0060921</pub-id><pub-id pub-id-type="pmid">23577177</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kujala</surname><given-names>P.</given-names></name><name><surname>Raymond</surname><given-names>C. R.</given-names></name><name><surname>Romeijn</surname><given-names>M.</given-names></name><name><surname>Godsave</surname><given-names>S. F.</given-names></name><name><surname>van Kasteren</surname><given-names>S. I.</given-names></name><name><surname>Wille</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Prion uptake in the gut: identification of the first uptake and replication sites</article-title>. <source/>PLoS Pathog.
<volume>7</volume>:<fpage>e1002449</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1002449</pub-id><pub-id pub-id-type="pmid">22216002</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>D. K. V.</given-names></name><name><surname>Choi</surname><given-names>S. H.</given-names></name><name><surname>Washicosky</surname><given-names>K. J.</given-names></name><name><surname>Eimer</surname><given-names>W. A.</given-names></name><name><surname>Tucker</surname><given-names>S.</given-names></name><name><surname>Ghofrani</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer’s disease</article-title>. <source/>Sci. Transl. Med.
<volume>8</volume>:<fpage>340ra72</fpage>. <pub-id pub-id-type="doi">10.1126/scitranslmed.aaf1059</pub-id><pub-id pub-id-type="pmid">27225182</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>S.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Hu</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Jin</surname><given-names>F.</given-names></name></person-group> (<year>2018</year>). <article-title>Recognizing depression from the microbiota-gut-brain axis</article-title>. <source/>Int. J. Mol. Sci.
<volume>19</volume>:<fpage>E1592</fpage>. <pub-id pub-id-type="doi">10.1007/978-981-10-6580-4_17</pub-id><pub-id pub-id-type="pmid">29843470</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liddelow</surname><given-names>S. A.</given-names></name><name><surname>Guttenplan</surname><given-names>K. A.</given-names></name><name><surname>Clarke</surname><given-names>L. E.</given-names></name><name><surname>Bennett</surname><given-names>F. C.</given-names></name><name><surname>Bohlen</surname><given-names>C. J.</given-names></name><name><surname>Schirmer</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Neurotoxic reactive astrocytes are induced by activated microglia</article-title>. <source/>Nature
<volume>541</volume>, <fpage>481</fpage>–<lpage>487</lpage>. <pub-id pub-id-type="doi">10.1038/nature21029</pub-id><pub-id pub-id-type="pmid">28099414</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>L.</given-names></name><name><surname>Zheng</surname><given-names>L. J.</given-names></name><name><surname>Zhang</surname><given-names>L. J.</given-names></name></person-group> (<year>2018</year>). <article-title>Neuroinflammation, gut microbiome and Alzheimer’s disease</article-title>. <source/>Mol. Neurobiol.
<volume>55</volume>, <fpage>8243</fpage>–<lpage>8250</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-018-0983-2</pub-id><pub-id pub-id-type="pmid">29524051</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luczynski</surname><given-names>P.</given-names></name><name><surname>Whelan</surname><given-names>S. O.</given-names></name><name><surname>O’Sullivan</surname><given-names>C.</given-names></name><name><surname>Clarke</surname><given-names>G.</given-names></name><name><surname>Shanahan</surname><given-names>F.</given-names></name><name><surname>Dinan</surname><given-names>T. G.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Adult microbiota-deficient mice have distinct dendritic morphological changes: differential effects in the amygdala and hippocampus</article-title>. <source/>Eur. J. Neurosci.
<volume>44</volume>, <fpage>2654</fpage>–<lpage>2666</lpage>. <pub-id pub-id-type="doi">10.1111/ejn.13291</pub-id><pub-id pub-id-type="pmid">27256072</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lukiw</surname><given-names>W. J.</given-names></name></person-group> (<year>2016</year>). <article-title><italic>Bacteroides fragilis</italic> lipopolysaccharide and inflammatory signaling in Alzheimer’s disease</article-title>. <source/>Front. Microbiol.
<volume>7</volume>:<fpage>1544</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2016.01544</pub-id><pub-id pub-id-type="pmid">27725817</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maalouf</surname><given-names>M.</given-names></name><name><surname>Rho</surname><given-names>J. M.</given-names></name><name><surname>Mattson</surname><given-names>M. P.</given-names></name></person-group> (<year>2009</year>). <article-title>The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies</article-title>. <source/>Brain Res. Rev.
<volume>59</volume>, <fpage>293</fpage>–<lpage>315</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresrev.2008.09.002</pub-id><pub-id pub-id-type="pmid">18845187</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marizzoni</surname><given-names>M.</given-names></name><name><surname>Provasi</surname><given-names>S.</given-names></name><name><surname>Cattaneo</surname><given-names>A.</given-names></name><name><surname>Frisoni</surname><given-names>G. B.</given-names></name></person-group> (<year>2017</year>). <article-title>Microbiota and neurodegenerative diseases</article-title>. <source/>Curr. Opin. Neurol.
<volume>30</volume>, <fpage>630</fpage>–<lpage>638</lpage>. <pub-id pub-id-type="doi">10.1097/WCO.0000000000000496</pub-id><pub-id pub-id-type="pmid">28906270</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matcovitch-Natan</surname><given-names>O.</given-names></name><name><surname>Winter</surname><given-names>D. R.</given-names></name><name><surname>Giladi</surname><given-names>A.</given-names></name><name><surname>Vargas Aguilar</surname><given-names>S.</given-names></name><name><surname>Spinrad</surname><given-names>A.</given-names></name><name><surname>Sarrazin</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Microglia development follows a stepwise program to regulate brain homeostasis</article-title>. <source/>Science
<volume>353</volume>:<fpage>aad8670</fpage>. <pub-id pub-id-type="doi">10.1126/science.aad8670</pub-id><pub-id pub-id-type="pmid">27338705</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matheoud</surname><given-names>D.</given-names></name><name><surname>Cannon</surname><given-names>T.</given-names></name><name><surname>Voisin</surname><given-names>A.</given-names></name><name><surname>Penttinen</surname><given-names>A.-M.</given-names></name><name><surname>Ramet</surname><given-names>L.</given-names></name><name><surname>Fahmy</surname><given-names>A. M.</given-names></name><etal></etal></person-group>. (<year>2019</year>). <article-title>Intestinal infection triggers Parkinson’s disease-like symptoms in Pink1<sup>−/−</sup> mice</article-title>. <source/>Nature
<volume>571</volume>, <fpage>565</fpage>–<lpage>569</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-019-1405-y</pub-id><pub-id pub-id-type="pmid">31316206</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGeer</surname><given-names>P. L.</given-names></name><name><surname>McGeer</surname><given-names>E. G.</given-names></name></person-group> (<year>2002</year>). <article-title>Local neuroinflammation and the progression of Alzheimer’s disease</article-title>. <source/>J. Neurovirol.
<volume>8</volume>, <fpage>529</fpage>–<lpage>538</lpage>. <pub-id pub-id-type="doi">10.1080/13550280290100969</pub-id><pub-id pub-id-type="pmid">12476347</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minter</surname><given-names>M. R.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Leone</surname><given-names>V.</given-names></name><name><surname>Ringus</surname><given-names>D. L.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Oyler-Castrillo</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer’s disease</article-title>. <source/>Sci. Rep.
<volume>6</volume>:<fpage>30028</fpage>. <pub-id pub-id-type="doi">10.1038/srep30028</pub-id><pub-id pub-id-type="pmid">27443609</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Musa</surname><given-names>N. H.</given-names></name><name><surname>Mani</surname><given-names>V.</given-names></name><name><surname>Lim</surname><given-names>S. M.</given-names></name><name><surname>Vidyadaran</surname><given-names>S.</given-names></name><name><surname>Abdul Majeed</surname><given-names>A. B.</given-names></name><name><surname>Ramasamy</surname><given-names>K.</given-names></name></person-group> (<year>2017</year>). <article-title>Lactobacilli-fermented cow’s milk attenuated lipopolysaccharide-induced neuroinflammation and memory impairment <italic>in vitro</italic> and <italic>in vivo</italic></article-title>. <source/>J. Dairy Res.
<volume>84</volume>, <fpage>488</fpage>–<lpage>495</lpage>. <pub-id pub-id-type="doi">10.1017/S0022029917000620</pub-id><pub-id pub-id-type="pmid">29154736</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Toole</surname><given-names>G.</given-names></name><name><surname>Kaplan</surname><given-names>H. B.</given-names></name><name><surname>Kolter</surname><given-names>R.</given-names></name></person-group> (<year>2000</year>). <article-title>Biofilm formation as microbial development</article-title>. <source/>Annu. Rev. Microbiol.
<volume>54</volume>, <fpage>49</fpage>–<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.micro.54.1.49</pub-id><pub-id pub-id-type="pmid">11018124</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olson</surname><given-names>C. A.</given-names></name><name><surname>Vuong</surname><given-names>H. E.</given-names></name><name><surname>Yano</surname><given-names>J. M.</given-names></name><name><surname>Liang</surname><given-names>Q. Y.</given-names></name><name><surname>Nusbaum</surname><given-names>D. J.</given-names></name><name><surname>Hsiao</surname><given-names>E. Y.</given-names></name></person-group> (<year>2018</year>). <article-title>The gut microbiota mediates the anti-seizure effects of the ketogenic diet</article-title>. <source/>Cell
<volume>173</volume>, <fpage>1728.e13</fpage>–<lpage>1741.e13</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2018.04.027</pub-id><pub-id pub-id-type="pmid">29804833</pub-id></mixed-citation>
</ref>
<ref id="B202">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pani</surname><given-names>G.</given-names></name></person-group> (<year>2015</year>). <article-title>Neuroprotective effects of dietary restriction: Evidence and mechanisms</article-title>. <source/>Semin. Cell Dev. Biol.
<volume>40</volume>, <fpage>106</fpage>–<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcdb.2015.03.004</pub-id><pub-id pub-id-type="pmid">25773162</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panza</surname><given-names>F.</given-names></name><name><surname>Lozupone</surname><given-names>M.</given-names></name><name><surname>Logroscino</surname><given-names>G.</given-names></name><name><surname>Imbimbo</surname><given-names>B. P.</given-names></name></person-group> (<year>2019</year>). <article-title>A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease</article-title>. <source/>Nat. Rev. Neurol.
<volume>15</volume>, <fpage>73</fpage>–<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1038/s41582-018-0116-6</pub-id><pub-id pub-id-type="pmid">30610216</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pistollato</surname><given-names>F.</given-names></name><name><surname>Iglesias</surname><given-names>R. C.</given-names></name><name><surname>Ruiz</surname><given-names>R.</given-names></name><name><surname>Aparicio</surname><given-names>S.</given-names></name><name><surname>Crespo</surname><given-names>J.</given-names></name><name><surname>Lopez</surname><given-names>L. D.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Nutritional patterns associated with the maintenance of neurocognitive functions and the risk of dementia and Alzheimer’s disease: a focus on human studies</article-title>. <source/>Pharmacol. Res.
<volume>131</volume>, <fpage>32</fpage>–<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2018.03.012</pub-id><pub-id pub-id-type="pmid">29555333</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plaza-Díaz</surname><given-names>J.</given-names></name><name><surname>Ruiz-Ojeda</surname><given-names>F.</given-names></name><name><surname>Vilchez-Padial</surname><given-names>L.</given-names></name><name><surname>Gil</surname><given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>Evidence of the anti-inflammatory effects of probiotics and synbiotics in intestinal chronic diseases</article-title>. <source/>Nutrients
<volume>9</volume>:<fpage>E555</fpage>. <pub-id pub-id-type="doi">10.3390/nu9060555</pub-id><pub-id pub-id-type="pmid">28555037</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rangaraju</surname><given-names>S.</given-names></name><name><surname>Dammer</surname><given-names>E. B.</given-names></name><name><surname>Raza</surname><given-names>S. A.</given-names></name><name><surname>Gao</surname><given-names>T.</given-names></name><name><surname>Xiao</surname><given-names>H.</given-names></name><name><surname>Betarbet</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer’s disease-related proteins</article-title>. <source/>Mol. Neurodegener.
<volume>13</volume>:<fpage>34</fpage>. <pub-id pub-id-type="doi">10.1186/s13024-018-0266-4</pub-id><pub-id pub-id-type="pmid">29954413</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogers</surname><given-names>J.</given-names></name><name><surname>Cooper</surname><given-names>N. R.</given-names></name><name><surname>Webster</surname><given-names>S.</given-names></name><name><surname>Schultz</surname><given-names>J.</given-names></name><name><surname>McGeer</surname><given-names>P. L.</given-names></name><name><surname>Styren</surname><given-names>S. D.</given-names></name><etal></etal></person-group>. (<year>1992</year>). <article-title>Complement activation by β-amyloid in Alzheimer disease</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>89</volume>, <fpage>10016</fpage>–<lpage>10020</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.89.21.10016</pub-id><pub-id pub-id-type="pmid">1438191</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rooks</surname><given-names>M. G.</given-names></name><name><surname>Garrett</surname><given-names>W. S.</given-names></name></person-group> (<year>2016</year>). <article-title>Gut microbiota, metabolites and host immunity</article-title>. <source/>Nat. Rev. Immunol.
<volume>16</volume>, <fpage>341</fpage>–<lpage>352</lpage>. <pub-id pub-id-type="doi">10.1038/nri.2016.42</pub-id><pub-id pub-id-type="pmid">27231050</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Round</surname><given-names>J. L.</given-names></name><name><surname>Mazmanian</surname><given-names>S. K.</given-names></name></person-group> (<year>2009</year>). <article-title>The gut microbiota shapes intestinal immune responses during health and disease</article-title>. <source/>Nat. Rev. Immunol.
<volume>9</volume>, <fpage>313</fpage>–<lpage>323</lpage>. <pub-id pub-id-type="doi">10.1038/nri2515</pub-id><pub-id pub-id-type="pmid">19343057</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santoro</surname><given-names>A.</given-names></name><name><surname>Ostan</surname><given-names>R.</given-names></name><name><surname>Candela</surname><given-names>M.</given-names></name><name><surname>Biagi</surname><given-names>E.</given-names></name><name><surname>Brigidi</surname><given-names>P.</given-names></name><name><surname>Capri</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Gut microbiota changes in the extreme decades of human life: a focus on centenarians</article-title>. <source/>Cell. Mol. Life Sci.
<volume>75</volume>, <fpage>129</fpage>–<lpage>148</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-017-2674-y</pub-id><pub-id pub-id-type="pmid">29032502</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos</surname><given-names>S. F.</given-names></name><name><surname>de Oliveira</surname><given-names>H. L.</given-names></name><name><surname>Yamada</surname><given-names>E. S.</given-names></name><name><surname>Neves</surname><given-names>B. C.</given-names></name><name><surname>Pereira</surname><given-names>A.</given-names></name></person-group> (<year>2019</year>). <article-title>The gut and Parkinson’s disease—a bidirectional pathway</article-title>. <source/>Front. Neurol.
<volume>10</volume>:<fpage>574</fpage>. <pub-id pub-id-type="doi">10.3389/fneur.2019.00574</pub-id><pub-id pub-id-type="pmid">31214110</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheperjans</surname><given-names>F.</given-names></name><name><surname>Aho</surname><given-names>V.</given-names></name><name><surname>Pereira</surname><given-names>P. A. B.</given-names></name><name><surname>Koskinen</surname><given-names>K.</given-names></name><name><surname>Paulin</surname><given-names>L.</given-names></name><name><surname>Pekkonen</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Gut microbiota are related to Parkinson’s disease and clinical phenotype</article-title>. <source/>Mov. Disord.
<volume>30</volume>, <fpage>350</fpage>–<lpage>358</lpage>. <pub-id pub-id-type="doi">10.1002/mds.26069</pub-id><pub-id pub-id-type="pmid">25476529</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schönfeld</surname><given-names>P.</given-names></name><name><surname>Wojtczak</surname><given-names>L.</given-names></name></person-group> (<year>2016</year>). <article-title>Short- and medium-chain fatty acids in energy metabolism: the cellular perspective</article-title>. <source/>J. Lipid Res.
<volume>57</volume>, <fpage>943</fpage>–<lpage>954</lpage>. <pub-id pub-id-type="doi">10.1194/jlr.r067629</pub-id><pub-id pub-id-type="pmid">27080715</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharon</surname><given-names>G.</given-names></name><name><surname>Sampson</surname><given-names>T. R.</given-names></name><name><surname>Geschwind</surname><given-names>D. H.</given-names></name><name><surname>Mazmanian</surname><given-names>S. K.</given-names></name></person-group> (<year>2016</year>). <article-title>The central nervous system and the gut microbiome</article-title>. <source/>Cell
<volume>167</volume>, <fpage>915</fpage>–<lpage>932</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2016.10.027</pub-id><pub-id pub-id-type="pmid">27814521</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Ji</surname><given-names>H.-F.</given-names></name></person-group> (<year>2017</year>). <article-title>Alzheimer’s disease histological and behavioral manifestations in transgenic mice correlate with specific gut microbiome state</article-title>. <source/>J. Alzheimers Dis.
<volume>56</volume>, <fpage>385</fpage>–<lpage>390</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-160884</pub-id><pub-id pub-id-type="pmid">27911317</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shirooie</surname><given-names>S.</given-names></name><name><surname>Nabavi</surname><given-names>S. F.</given-names></name><name><surname>Dehpour</surname><given-names>A. R.</given-names></name><name><surname>Belwal</surname><given-names>T.</given-names></name><name><surname>Habtemariam</surname><given-names>S.</given-names></name><name><surname>Argüelles</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Targeting mTORs by omega-3 fatty acids: a possible novel therapeutic strategy for neurodegeneration?</article-title>
<source/>Pharmacol. Res.
<volume>135</volume>, <fpage>37</fpage>–<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2018.07.004</pub-id><pub-id pub-id-type="pmid">29990625</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sieber</surname><given-names>C. C.</given-names></name></person-group> (<year>2019</year>). <article-title>Malnutrition and sarcopenia</article-title>. <source/>Aging Clin. Exp. Res.
<volume>31</volume>, <fpage>793</fpage>–<lpage>798</lpage>. <pub-id pub-id-type="doi">10.1007/s40520-019-01170-1</pub-id><pub-id pub-id-type="pmid">31148100</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sigal</surname><given-names>M.</given-names></name><name><surname>Meyer</surname><given-names>T. F.</given-names></name></person-group> (<year>2016</year>). <article-title>Coevolution between the human microbiota and the epithelial immune system</article-title>. <source/>Dig. Dis.
<volume>34</volume>, <fpage>190</fpage>–<lpage>193</lpage>. <pub-id pub-id-type="doi">10.1159/000443349</pub-id><pub-id pub-id-type="pmid">27028060</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sochocka</surname><given-names>M.</given-names></name><name><surname>Donskow-Łysoniewska</surname><given-names>K.</given-names></name><name><surname>Diniz</surname><given-names>B. S.</given-names></name><name><surname>Kurpas</surname><given-names>D.</given-names></name><name><surname>Brzozowska</surname><given-names>E.</given-names></name><name><surname>Leszek</surname><given-names>J.</given-names></name></person-group> (<year>2019</year>). <article-title>The gut microbiome alterations and inflammation-driven pathogenesis of Alzheimer’s disease—a critical review</article-title>. <source/>Mol. Neurobiol.
<volume>56</volume>, <fpage>1841</fpage>–<lpage>1851</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-018-1188-4</pub-id><pub-id pub-id-type="pmid">29936690</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sohn</surname><given-names>E.</given-names></name></person-group> (<year>2018</year>). <article-title>How the evidence stacks up for preventing Alzheimer’s disease</article-title>. <source/>Nature
<volume>559</volume>, <fpage>S18</fpage>–<lpage>S20</lpage>. <pub-id pub-id-type="doi">10.1038/d41586-018-05724-7</pub-id><pub-id pub-id-type="pmid">30046084</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soscia</surname><given-names>S. J.</given-names></name><name><surname>Kirby</surname><given-names>J. E.</given-names></name><name><surname>Washicosky</surname><given-names>K. J.</given-names></name><name><surname>Tucker</surname><given-names>S. M.</given-names></name><name><surname>Ingelsson</surname><given-names>M.</given-names></name><name><surname>Hyman</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>The Alzheimer’s disease-associated amyloid β-protein is an antimicrobial peptide</article-title>. <source/>PLoS One
<volume>5</volume>:<fpage>e9505</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0009505</pub-id><pub-id pub-id-type="pmid">20209079</pub-id></mixed-citation>
</ref>
<ref id="B201">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stafstrom</surname><given-names>C. E.</given-names></name><name><surname>Rho</surname><given-names>J. M.</given-names></name></person-group> (<year>2012</year>). <article-title>The Ketogenic Diet as a Treatment Paradigm for Diverse Neurological Disorders</article-title>. <source/>Front. Pharmacol.
<volume>3</volume>:<fpage>59</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2012.00059</pub-id><pub-id pub-id-type="pmid">22509165</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sudo</surname><given-names>N.</given-names></name><name><surname>Chida</surname><given-names>Y.</given-names></name><name><surname>Aiba</surname><given-names>Y.</given-names></name><name><surname>Sonoda</surname><given-names>J.</given-names></name><name><surname>Oyama</surname><given-names>N.</given-names></name><name><surname>Yu</surname><given-names>X.-N.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice</article-title>. <source/>J. Physiol.
<volume>558</volume>, <fpage>263</fpage>–<lpage>275</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2004.063388</pub-id><pub-id pub-id-type="pmid">15133062</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanca</surname><given-names>A.</given-names></name><name><surname>Abbondio</surname><given-names>M.</given-names></name><name><surname>Palomba</surname><given-names>A.</given-names></name><name><surname>Fraumene</surname><given-names>C.</given-names></name><name><surname>Marongiu</surname><given-names>F.</given-names></name><name><surname>Serra</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Caloric restriction promotes functional changes involving short-chain fatty acid biosynthesis in the rat gut microbiota</article-title>. <source/>Sci. Rep.
<volume>8</volume>:<fpage>14778</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-018-33100-y</pub-id><pub-id pub-id-type="pmid">30283130</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thevaranjan</surname><given-names>N.</given-names></name><name><surname>Puchta</surname><given-names>A.</given-names></name><name><surname>Schulz</surname><given-names>C.</given-names></name><name><surname>Naidoo</surname><given-names>A.</given-names></name><name><surname>Szamosi</surname><given-names>J. C.</given-names></name><name><surname>Verschoor</surname><given-names>C. P.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Age-associated microbial dysbiosis promotes intestinal permeability, systemic inflammation, and macrophage dysfunction</article-title>. <source/>Cell Host Microbe
<volume>23</volume>:<fpage>570</fpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2018.03.006</pub-id><pub-id pub-id-type="pmid">29649447</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ticinesi</surname><given-names>A.</given-names></name><name><surname>Lauretani</surname><given-names>F.</given-names></name><name><surname>Tana</surname><given-names>C.</given-names></name><name><surname>Nouvenne</surname><given-names>A.</given-names></name><name><surname>Ridolo</surname><given-names>E.</given-names></name><name><surname>Meschi</surname><given-names>T.</given-names></name></person-group> (<year>2019</year>). <article-title>Exercise and immune system as modulators of intestinal microbiome: implications for the gut-muscle axis hypothesis</article-title>. <source/>Exerc. Immunol. Rev.
<volume>25</volume>, <fpage>84</fpage>–<lpage>95</lpage>. <pub-id pub-id-type="pmid">30753131</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tremaroli</surname><given-names>V.</given-names></name><name><surname>Bäckhed</surname><given-names>F.</given-names></name></person-group> (<year>2012</year>). <article-title>Functional interactions between the gut microbiota and host metabolism</article-title>. <source/>Nature
<volume>489</volume>, <fpage>242</fpage>–<lpage>249</lpage>. <pub-id pub-id-type="doi">10.1038/nature11552</pub-id><pub-id pub-id-type="pmid">22972297</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ulusoy</surname><given-names>A.</given-names></name><name><surname>Musgrove</surname><given-names>R. E.</given-names></name><name><surname>Rusconi</surname><given-names>R.</given-names></name><name><surname>Klinkenberg</surname><given-names>M.</given-names></name><name><surname>Helwig</surname><given-names>M.</given-names></name><name><surname>Schneider</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Neuron-to-neuron α-synuclein propagation <italic>in vivo</italic> is independent of neuronal injury</article-title>. <source/>Acta Neuropathol. Commun.
<volume>3</volume>:<fpage>13</fpage>. <pub-id pub-id-type="doi">10.1186/s40478-015-0198-y</pub-id><pub-id pub-id-type="pmid">25853980</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vogt</surname><given-names>N. M.</given-names></name><name><surname>Kerby</surname><given-names>R. L.</given-names></name><name><surname>Dill-McFarland</surname><given-names>K. A.</given-names></name><name><surname>Harding</surname><given-names>S. J.</given-names></name><name><surname>Merluzzi</surname><given-names>A. P.</given-names></name><name><surname>Johnson</surname><given-names>S. C.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Gut microbiome alterations in Alzheimer’s disease</article-title>. <source/>Sci. Rep.
<volume>7</volume>:<fpage>13537</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-13601-y</pub-id><pub-id pub-id-type="pmid">29051531</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wahl</surname><given-names>D.</given-names></name><name><surname>Solon-Biet</surname><given-names>S. M.</given-names></name><name><surname>Cogger</surname><given-names>V. C.</given-names></name><name><surname>Fontana</surname><given-names>L.</given-names></name><name><surname>Simpson</surname><given-names>S. J.</given-names></name><name><surname>Le Couteur</surname><given-names>D. G.</given-names></name><etal></etal></person-group>. (<year>2019</year>). <article-title>Aging, lifestyle and dementia</article-title>. <source/>Neurobiol. Dis.
<volume>130</volume>:<fpage>104481</fpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2019.104481</pub-id><pub-id pub-id-type="pmid">31136814</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>L. C.</given-names></name><name><surname>Schelle</surname><given-names>J.</given-names></name><name><surname>Jucker</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>The prion-like properties of amyloid-β assemblies: implications for Alzheimer’s disease</article-title>. <source/>Cold Spring Harb. Perspect. Med.
<volume>6</volume>:<fpage>a024398</fpage>. <pub-id pub-id-type="doi">10.1101/cshperspect.a024398</pub-id><pub-id pub-id-type="pmid">27270558</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinhard</surname><given-names>L.</given-names></name><name><surname>di Bartolomei</surname><given-names>G.</given-names></name><name><surname>Bolasco</surname><given-names>G.</given-names></name><name><surname>Machado</surname><given-names>P.</given-names></name><name><surname>Schieber</surname><given-names>N. L.</given-names></name><name><surname>Neniskyte</surname><given-names>U.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Microglia remodel synapses by presynaptic trogocytosis and spine head filopodia induction</article-title>. <source/>Nat. Commun.
<volume>9</volume>:<fpage>1228</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-018-03566-5</pub-id><pub-id pub-id-type="pmid">29581545</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wellman</surname><given-names>A. S.</given-names></name><name><surname>Metukuri</surname><given-names>M. R.</given-names></name><name><surname>Kazgan</surname><given-names>N.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Xu</surname><given-names>Q.</given-names></name><name><surname>Ren</surname><given-names>N. S. X.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Intestinal epithelial sirtuin 1 regulates intestinal inflammation during aging in mice by altering the intestinal microbiota</article-title>. <source/>Gastroenterology
<volume>153</volume>, <fpage>772</fpage>–<lpage>786</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2017.05.022</pub-id><pub-id pub-id-type="pmid">28552621</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wes</surname><given-names>P. D.</given-names></name><name><surname>Holtman</surname><given-names>I. R.</given-names></name><name><surname>Boddeke</surname><given-names>E. W. G. M.</given-names></name><name><surname>Möller</surname><given-names>T.</given-names></name><name><surname>Eggen</surname><given-names>B. J. L.</given-names></name></person-group> (<year>2016</year>). <article-title>Next generation transcriptomics and genomics elucidate biological complexity of microglia in health and disease: transcriptomics and genomics of Microglia</article-title>. <source/>Glia
<volume>64</volume>, <fpage>197</fpage>–<lpage>213</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22866</pub-id><pub-id pub-id-type="pmid">26040959</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>M. R.</given-names></name><name><surname>Kandel</surname><given-names>R.</given-names></name><name><surname>Tripathi</surname><given-names>S.</given-names></name><name><surname>Condon</surname><given-names>D.</given-names></name><name><surname>Qi</surname><given-names>L.</given-names></name><name><surname>Taubenberger</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Alzheimer’s associated β-amyloid protein inhibits influenza A virus and modulates viral interactions with phagocytes</article-title>. <source/>PLoS One
<volume>9</volume>:<fpage>e101364</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0101364</pub-id><pub-id pub-id-type="pmid">24988208</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Włodarek</surname><given-names>D.</given-names></name></person-group> (<year>2019</year>). <article-title>Role of ketogenic diets in neurodegenerative diseases (Alzheimer’s disease and Parkinson’s disease)</article-title>. <source/>Nutrients
<volume>11</volume>:<fpage>E169</fpage>. <pub-id pub-id-type="doi">10.3390/nu11010169</pub-id><pub-id pub-id-type="pmid">30650523</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>M.-Q.</given-names></name><name><surname>Cao</surname><given-names>H. L.</given-names></name><name><surname>Wang</surname><given-names>W. Q.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Cao</surname><given-names>X. C.</given-names></name><name><surname>Yan</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Fecal microbiota transplantation broadening its application beyond intestinal disorders</article-title>. <source/>World J. Gastroenterol.
<volume>21</volume>, <fpage>102</fpage>–<lpage>211</lpage>. <pub-id pub-id-type="doi">10.3748/wjg.v21.i1.102</pub-id><pub-id pub-id-type="pmid">25574083</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhan</surname><given-names>X.</given-names></name><name><surname>Stamova</surname><given-names>B.</given-names></name><name><surname>Jin</surname><given-names>L.-W.</given-names></name><name><surname>DeCarli</surname><given-names>C.</given-names></name><name><surname>Phinney</surname><given-names>B.</given-names></name><name><surname>Sharp</surname><given-names>F. R.</given-names></name></person-group> (<year>2016</year>). <article-title>Gram-negative bacterial molecules associate with Alzheimer disease pathology</article-title>. <source/>Neurology
<volume>87</volume>, <fpage>2324</fpage>–<lpage>2332</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0000000000003391</pub-id><pub-id pub-id-type="pmid">27784770</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Huang</surname><given-names>P.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Structural modulation of gut microbiota in life-long calorie-restricted mice</article-title>. <source/>Nat. Commun.
<volume>4</volume>:<fpage>2163</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms3163</pub-id><pub-id pub-id-type="pmid">23860099</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Jaber</surname><given-names>V.</given-names></name><name><surname>Lukiw</surname><given-names>W. J.</given-names></name></person-group> (<year>2017</year>). <article-title>Secretory products of the human GI tract microbiome and their potential impact on Alzheimer’s disease (AD): detection of lipopolysaccharide (LPS) in AD hippocampus</article-title>. <source/>Front. Cell. Infect. Microbiol.
<volume>7</volume>:<fpage>318</fpage>. <pub-id pub-id-type="doi">10.3389/fcimb.2017.00318</pub-id><pub-id pub-id-type="pmid">28744452</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Smith</surname><given-names>D.</given-names></name><name><surname>Leong</surname><given-names>B. J.</given-names></name><name><surname>Brännström</surname><given-names>K.</given-names></name><name><surname>Almqvist</surname><given-names>F.</given-names></name><name><surname>Chapman</surname><given-names>M. R.</given-names></name></person-group> (<year>2012</year>). <article-title>Promiscuous cross-seeding between bacterial amyloids promotes interspecies biofilms</article-title>. <source/>J. Biol. Chem.
<volume>287</volume>, <fpage>35092</fpage>–<lpage>35103</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m112.383737</pub-id><pub-id pub-id-type="pmid">22891247</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zullo</surname><given-names>A.</given-names></name><name><surname>Simone</surname><given-names>E.</given-names></name><name><surname>Grimaldi</surname><given-names>M.</given-names></name><name><surname>Musto</surname><given-names>V.</given-names></name><name><surname>Mancini</surname><given-names>F.</given-names></name></person-group> (<year>2018</year>). <article-title>Sirtuins as mediator of the anti-ageing effects of calorie restriction in skeletal and cardiac muscle</article-title>. <source/>Int. J. Mol. Sci.
<volume>19</volume>:<fpage>E928</fpage>. <pub-id pub-id-type="doi">10.3390/ijms19040928</pub-id><pub-id pub-id-type="pmid">29561771</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>